# Prevalence of DAO (diamino Oxidase) Deficiency in Newborns

> **NCT06710366** · — · COMPLETED · sponsor: **AB Biotek** · enrollment: 200 (actual)

## Conditions studied

- DAO Genetic Variants

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06710366
- **Lead sponsor:** AB Biotek
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-28
- **Primary completion:** 2024-06-21
- **Final completion:** 2024-06-26
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2024-11-29

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06710366

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06710366, "Prevalence of DAO (diamino Oxidase) Deficiency in Newborns". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06710366. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*